Trials / Conditions / Non-Proliferative Diabetic Retinopathy

Non-Proliferative Diabetic Retinopathy

30 registered clinical trials studyying Non-Proliferative Diabetic Retinopathy — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Study to Evaluate the Efficacy and Safety of OTX-TKI (Axitinib Implant) in Participants With Non-Proliferati NCT07235085	Ocular Therapeutix, Inc.	Phase 3
Recruiting	Safety and Proof of Concept Study of ANXV (Annexin A5) in Patients With Diabetic Retinopathy or Retinal Vein O NCT07259928	Annexin Pharmaceuticals AB	Phase 2
Recruiting	Clinical Study on the Efficacy and Safety of TNTL in the Treatment of Non-proliferative Diabetic Retinopathy NCT06817265	Beletalent (Zhuhai) Pharmaceutical Co., Ltd	Phase 3
Recruiting	Remote Ischemic Conditioning for Non-Proliferative Diabetic Retinopathy NCT06713720	Xuxiang Zhang, MD	N/A
Completed	A Study to Learn How Safe BAY3283142 is When Taken as a Single Dose or as Multiple Doses in Healthy Chinese Pa NCT06487845	Bayer	Phase 1
Completed	Safety and Efficacy of Faricimab in Patients With NPDR NCT05681884	Greater Houston Retina Research	Phase 2
Unknown	Study to Evaluate the Safety, Tolerability, and Efficacy of OTX-TKI in Subjects With Moderately Severe to Seve NCT05695417	Ocular Therapeutix, Inc.	Phase 1
Active Not Recruiting	Phase 2 Spectra Study to Evaluate the Safety and Efficacy of OPL-0401 in Patients With Diabetic Retinopathy NCT05393284	Valo Health, Inc.	Phase 2
Unknown	Study to Evaluate Efficacy and Safety of Entelon 50mg in Patients With Non-Proliferative Diabetic Retinopathy NCT05358080	Hanlim Pharm. Co., Ltd.	Phase 4
Completed	To Evaluate the Efficacy and Safety of Combination Therapy With B55R1 and B55R2 Compared to B55R1 Monotherapy NCT07230184	AJU Pharm Co., Ltd.	Phase 4
Enrolling By Invitation	Intravitreal and Intracameral DEX in NPDR NCT06951087	Affiliated Hospital of Nantong University	Phase 3
Unknown	Anti-VEGF in Real-world NCT05222633	Wenbin Wei	—
Terminated	A Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 in Non-proliferative Diabetic Retinopathy NCT05066230	Kodiak Sciences Inc	Phase 3
Unknown	Intravitreal Bevacizumab for Nonproliferative Diabetic Retinopathy NCT04511715	Shahid Beheshti University of Medical Sciences	Phase 2 / Phase 3
Unknown	Pars-plana Vitrectomy vs Panretinal Photocoagulation for Severe NPDR NCT04103671	Zhongshan Ophthalmic Center, Sun Yat-sen University	N/A
Unknown	The Effect of Combination of Vitamin A, Vitamin E, Sodium Hyaluronate 0.15% Eye Drop Compared With Sodium Hyal NCT04000789	Dr Cipto Mangunkusumo General Hospital	N/A
Unknown	Diabetic Macular Edema - Obstructive Sleep Apnea Relationship Study NCT03597815	Uptown Eye Specialists	—
Completed	A Clinical Trial Designed to Evaluate the Safety and Efficacy Study of Luminate® in Inducing PVD (Posterior Vi NCT02435862	Allegro Ophthalmics, LLC	Phase 2
Completed	Nepafenac Once Daily for Macular Edema - Study 1 NCT01853072	Alcon Research	Phase 3
Completed	Bevacizumab and Peripheral Retinal Changes on Wide Field Angiography in Diabetic Macular Edema NCT02096874	King Khaled Eye Specialist Hospital	Phase 4
Completed	Nepafenac Once Daily for Macular Edema - Study 2 NCT01872611	Alcon Research	Phase 3
Unknown	Phase III Study of Compound Danshen Dripping Pills to Treat Diabetic Retinopathy NCT02388984	Tasly Pharmaceuticals, Inc.	Phase 3
Unknown	Effect of Folic Acid, Vitamin B6 and Vitamin B12 in Diabetic Retinopathy NCT01921192	University of Catania	Phase 4
Completed	Diabetes Visual Function Supplement Study NCT01646047	ZeaVision, LLC	N/A
Completed	Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema NCT01571232	Retina Macula Institute	Phase 2
Completed	Efficacy of Ubiquinone and Combined Antioxidant Therapy in Non-proliferative Diabetic Retinopathy NCT02062034	University of Guadalajara	Phase 2
Completed	Identifying Progression of Retinal Disease in Eyes With NPDR in Diabetes Type 2 Using Non-invasive Procedures NCT01145599	European Vision Institute Clinical Research Network	—
Unknown	Blood-retinal Barrier Imaging and Neuropsychiatric Sequela in Type 2 Diabetes Mellitus NCT01107132	Soroka University Medical Center	—
Terminated	Changes in Macular Thickness After Patterns Scan Laser NCT00563628	Asociación para Evitar la Ceguera en México	Phase 4
Terminated	Changes in Electroretinogram and Contrast Sensitivity After PASCAL Treatment NCT00563043	Asociación para Evitar la Ceguera en México	Phase 4